Q85.83 coverage policies: Medicare and commercial payers

35 active Medicare policies list Q85.83, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for Q85.83

Free account. Policy pages stay open to everyone.

Medicare policies listing Q85.83

LCD · WPS-J5-L34614

Colonoscopy and Sigmoidoscopy-Diagnostic

J5 · Effective Oct 1, 2015

LCD · WPS-J8-L34614

Colonoscopy and Sigmoidoscopy-Diagnostic

J8 · Effective Oct 1, 2015

LCD · CGS-J15-L34005

Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy

J15 · Effective Oct 1, 2015

LCD · NORIDIAN-JE-L34213

Diagnostic and Therapeutic Colonoscopy

JE · Effective Oct 1, 2015

LCD · NORIDIAN-JF-L34213

Diagnostic and Therapeutic Colonoscopy

JF · Effective Oct 1, 2015

LCD · NGS-J6-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6 · Effective Oct 1, 2015

LCD · NGS-JK-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

JK · Effective Oct 1, 2015

LCD · CGS-J15-L34081

Endoscopy by Capsule

J15 · Effective Oct 1, 2015

LCD · CGS-J15-L39017

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

J15 · Effective Aug 21, 2022

LCD · NORIDIAN-JE-L38972

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Commercial payer policies listing Q85.83

1 policy from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Ambetter

Ambetter policies listing Q85.83, with the code’s status in each
Policy	Effective	Status of Q85.83
Concert Genetic Testing: Toxicology and Pharmacogenetics Version BPayerPolicy · AMBETTER-CONCERT-GENETIC-TESTING-TOXICOLOGY-AND-PHARMACOGENETICS-VERSION-B	Not recorded	Referenced